GM Advisory Group LLC Decreases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

GM Advisory Group LLC lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,182 shares of the biotechnology company’s stock after selling 131 shares during the period. GM Advisory Group LLC’s holdings in Axon Enterprise were worth $1,297,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Prestige Wealth Management Group LLC grew its holdings in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the 4th quarter worth $40,000. Brooklyn Investment Group bought a new stake in Axon Enterprise in the 3rd quarter worth $41,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise in the 4th quarter worth $45,000. Finally, Stonebridge Financial Group LLC bought a new stake in Axon Enterprise in the 4th quarter worth $53,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.7 %

Shares of NASDAQ AXON opened at $539.99 on Wednesday. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The stock has a market cap of $41.38 billion, a P/E ratio of 139.53, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm has a 50-day moving average of $592.66 and a 200 day moving average of $539.27. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on AXON shares. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock valued at $1,087,843 in the last three months. Company insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.